Molecular characterization of genotype 2 and 4 hepatitis C virus isolates in French blood donors

被引:25
作者
Cantaloube, Jean-Francois [1 ]
Gallian, Pierre [1 ]
Laperche, Syria [2 ]
Elghouzzi, Marie-Helene [3 ]
Piquet, Yves [4 ]
Bouchardeau, Francoise [2 ]
Jordier, Francois [1 ]
Biagini, Philippe [1 ]
Attoui, Houssam [5 ]
de Micco, Philippe [1 ]
机构
[1] CNRS, UMR 6578, Unite Emergence & Coevolut Virale, Etab Francais Sang Alpes Mediterranee, F-13005 Marseille, France
[2] Inst Natl Transfus Sanguine, Paris, France
[3] EFS Ile France, Rungis, France
[4] EFS Aquitaine Limousin, Bordeaux, France
[5] Inst Anim Hlth, Surrey, England
基金
英国生物技术与生命科学研究理事会;
关键词
HCV; genotyping; phylogeny; coalescence;
D O I
10.1002/jmv.21285
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The subtype distribution of 142 genotype 2 and 97 genotype 4 hepatitis C virus (HCV) isolates from the sera of 1,319 volunteer blood donors in France was determined by gene sequencing and by phylogenetic analysis of the NS5B region and El envelope. Findings underlined a wide range of subtypes in both genotypes, that is, 20 in HCV-2 and 11 in HCV-4. Eighteen of these 31 subtypes had not been defined previously. Some subtypes, that is, 2a, 2b, 2c, 2i, 2k, 4a, and 4d, showed numerous strains while subtypes in donors from West Africa or Central Africa showed an endemic profile with only a few strains. A Bayesian coalescence approach was used to estimate the demographic history of each HCV subtype. The estimated mean dates of the most recent common ancestors (MRCA) were 1,889 (confidence interval (CO, 1,842-1,930) for HCV-2a, 1,886 (CI, 1,843-1,921) for HCV-2b, 1,791 (CI, 1,699-1,848) for HCV-2c, 1,846 (CI, 1,803-1,878) for HCV-2i, 1,911 (CI, 1,879-1,937) for HCV-4a, and 1,957 (CI, 1,943-1,967) for HCV-4d. The period of spread for subtype 2b, 2c, and 2i was between 1900 and 1960 whereas rapid exponential spread for subtype 2a, 4a, and 4d occurred in the 1960s. The inferred histories of population growth indicated that transmission rates differed according to HCV subtype. These results may help to predict the future burden of HCV in France.
引用
收藏
页码:1732 / 1739
页数:8
相关论文
共 55 条
[11]   Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients [J].
Hinrichsen, H ;
Benhamou, Y ;
Wedemeyer, H ;
Reiser, M ;
Sentjens, RE ;
Calleja, JL ;
Forns, X ;
Erhardt, A ;
Crönlein, J ;
Chaves, RL ;
Yong, CL ;
Nehmiz, G ;
Steinmann, GG .
GASTROENTEROLOGY, 2004, 127 (05) :1347-1355
[12]  
Hultgren C, 2004, J HEPATOL, V40, P971, DOI [10.1016/j.jhep.2004.02.002, 10.1016/S0168-8278(04)00052-2]
[13]   GENOMIC STRUCTURE OF THE HUMAN PROTOTYPE STRAIN-H OF HEPATITIS-C VIRUS - COMPARISON WITH AMERICAN AND JAPANESE ISOLATES [J].
INCHAUSPE, G ;
ZEBEDEE, S ;
LEE, DH ;
SUGITANI, M ;
NASOFF, M ;
PRINCE, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10292-10296
[14]  
Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt
[15]  
92::AID-JMV2&gt
[16]  
3.0.CO
[17]  
2-I
[18]   A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg [J].
Kalinina, O ;
Norder, H ;
Mukomolov, S ;
Magnius, LO .
JOURNAL OF VIROLOGY, 2002, 76 (08) :4034-4043
[19]   T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C [J].
Kaplan, DE ;
Sugimoto, K ;
Ikeda, F ;
Stadanlick, J ;
Valiga, M ;
Shetty, K ;
Reddy, KR ;
Chang, KM .
HEPATOLOGY, 2005, 41 (06) :1365-1375
[20]   IMPORTED HEPATITIS-C VIRUS GENOTYPES IN JAPANESE HEMOPHILIACS [J].
KINOSHITA, T ;
MIYAKE, K ;
OKAMOTO, H ;
MISHIRO, S .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (01) :249-250